Snowball logo
logo
6005

Zhejiang CONBA Pharmaceutical Co Ltd

600572 • SHG
¥4.31+¥0.07  (1.65%)
Estimate
P/E
21.6
EPS
0.2
Beta
0.207
Growth
Revenue, YoY
7.3%
Net income, YoY
9.2%
FCF, YoY
41.56%
About the company
Ticker
600572
ISIN
CNE000001H86
Country
China
Sector (GICS)
Healthcare
Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of pharmaceuticals and health products in China. It offers medicines, Chinese patent medicines, chemical medicines, Chinese herbal medicine slices, and health products. The company also provides Chinese decoction pieces; over-the-counter medications; healthy consumer products, including nutritional supplements, hygiene products, healthy daily chemicals and food, and other self-care products; and processes agricultural products. In addition, it offers prescription pieces, formula granules, plant extracts, and other products. The company offers its products under Aokang, Jindi, Jinaikang, Qianliekang, Tianbaoning, Jinkang Su, Li, Zhixinyan, Kang Enbei, Baozhilin, and Yangyingtang brands. The company was formerly known as Lanxi Yunshan Pharmaceutical Factory and changed its name to Zhejiang CONBA Pharmaceutical Co.,Ltd. in October 1999. Zhejiang CONBA Pharmaceutical Co.,Ltd. was founded in 1969 and is headquartered in Hangzhou, China.

Frequently asked questions

What sector does Zhejiang CONBA Pharmaceutical Co Ltd (600572) operate in?

Zhejiang CONBA Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Zhejiang CONBA Pharmaceutical Co Ltd (600572) current stock price?

As of the latest data, Zhejiang CONBA Pharmaceutical Co Ltd stock price is CN¥4.31, with a previous close of CN¥4.24. Zhejiang CONBA Pharmaceutical Co Ltd gained CN¥0.07 in the last trading session, representing a 1.65% increase.

What is Zhejiang CONBA Pharmaceutical Co Ltd (600572) current market capitalization?

Zhejiang CONBA Pharmaceutical Co Ltd market cap is approximately 10.94 billion.

What is Zhejiang CONBA Pharmaceutical Co Ltd (600572) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.20.

What is Zhejiang CONBA Pharmaceutical Co Ltd (600572) Price-to-Earnings (P/E) ratio?

Zhejiang CONBA Pharmaceutical Co Ltd current P/E ratio is 21.55.

Does Zhejiang CONBA Pharmaceutical Co Ltd (600572) pay dividends?

No. Zhejiang CONBA Pharmaceutical Co Ltd does not pay a dividend.

What is Zhejiang CONBA Pharmaceutical Co Ltd (600572) beta (volatility) score?

Zhejiang CONBA Pharmaceutical Co Ltd has a beta of 0.207, indicating lower volatility than the overall market.